Results 1 to 10 of about 450,783 (333)

Angiotensin II receptor antagonists

Lancet, The, 2000
Blockade of the renin-angiotensin system began as a way of studying the pathogenesis of cardiovascular disease with specific pharmacological probes.
Michel Burnier, H R Brunner
exaly   +7 more sources

Spectrofluorimetric method for determination of some angiotensin II receptor antagonists

Journal of Pharmaceutical Analysis, 2012
A simple, rapid, accurate and highly sensitive spectrofluorimetric method has been developed for determination of some angiotensin II receptor antagonists (AIIRA's), namely Losartan potassium (Los-K), Irbesartan (Irb), Valsartan (Val) and Candesartan ...
Salwa R. El-Shaboury, Samiha A. Hussein, Niveen A. Mohamed, Mohamed M. El-Sutohy   +3 more
doaj   +4 more sources

Discontinuation of Heart Failure Pharmacotherapy in Older Adults With Frailty [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Guideline‐directed medical therapy (GDMT) improves outcomes in heart failure irrespective of frailty status. Nevertheless, the magnitude of frailty‐associated discontinuation of GDMT remains insufficiently studied.
Ryo Nakamaru, Shiori Nishimura, Hiraku Kumamaru, Kyohei Daigo, Kayo M. Walsh, Shun Kohsaka   +5 more
doaj   +2 more sources

Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review

HYPERTENSION, 2012
The objective was to analyze the outcome following prenatal exposure to angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin receptor antagonists (ARBs).
Tschumi, Sibylle, Bianchetti, Mario G, Simonetti, Giacomo D, Bullo, Marina, Bucher, Barbara S   +4 more
core   +2 more sources

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES

Кардиоваскулярная терапия и профилактика, 2013
This literature review focuses on the angiotensin II receptor antagonists as one of the new and promising classes of antihypertensive medications. Apart from their antihypertensive activity, these agents possess a number of other beneficial effects.
E. O. Taratukhin
doaj   +3 more sources

Difficult choice: angiotensin receptor antagonists

Российский кардиологический журнал, 2013
The paper is focussed on the therapeutic choice of angiotensin receptor antagonists (ARA). The author presents the data on the comparison between different sartans and their benefits which are not explained by the blood pressure reduction.
E. O. Taratukhin
doaj   +2 more sources

ACE inhibitors – angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

Open Access Emergency Medicine, 2010
T S Mohamed Saleem1, K Bharani1, K Gauthaman21Department of Pharmacology, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa Dist, Andhra Pradesh, India; 2Department of Drug Technology, Higher Institute of Medical Technology, Derna, LibyaAbstract:
T S Mohamed Saleem, K Bharani, K Gauthaman   +2 more
doaj   +1 more source

Contemporary Guideline‐Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Randomized trials and clinical guidelines support early initiation of guideline‐directed medical therapy (GDMT) for heart failure (HF). The EMPACE (Treatment Patterns of Guideline‐Directed Medical Therapies in Heart Failure Patients in the ...
Stephen J. Greene, Atif Adam, Niklas Schmedt, Christian Carlsen, Milou Brand, Eleanor Davies, Laurence Sophie Jouaville Abrouk, Juergen H. Prochaska, Phuong Tran, Ayman Alhamdow   +9 more
doaj   +2 more sources

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA

Zdravniški Vestnik, 2002
Background. In numerous clinical studies that tried to identify risk factors for progressive renal function loss, the severity of proteinuria correlated with the rate of renal function loss.
Tanja Kök, Radovan Hojs
doaj   +2 more sources

Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic

Biomedical Papers, 2022
Aims. Sub-analysis of a retrospective nation-wide observational analysis of heart failure (HF) epidemiology reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018 aimed at angiotensin-converting enzyme inhibitors ...
Renata Aiglova, Milos Taborsky, Marie Lazarova, Ludek Pavlu, Josef Danek, Jan Precek, Alexander Schee, Vit Gloger, Vlastimil Cernicek, Marek Vicha, Tomas Skala   +10 more
doaj   +1 more source